Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  73.00 0.88% 8,357.00 8,356.00 8,358.00 8,404.00 8,306.00 8,386.00 329,946 10:50:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 19,468.2 2,864.2 178.5 45.2 129,460

AstraZeneca Gets EU Marketing Authorization Recommendation

26/07/2021 7:37am

Dow Jones News

Astrazeneca (LSE:AZN)
Historical Stock Chart

From Jun 2021 to Dec 2021

Click Here for more Astrazeneca Charts.

By Sabela Ojea


AstraZeneca PLC said Monday that its Ultomiris drug has been recommended for marketing authorization in the European Union by the EMA Committee for Medicinal Products for Human Use, or CHMP.

The pharmaceutical major said the use of the drug has been expanded to include children and adolescents with paroxysmal nocturnal haemoglobinuria.

The opinion is based on results from an Ultomiris phase 3 trial, which showed an established efficacy and safety profile with reduced treatment burden for children with PNH and their families, the FTSE 100 listed company added.


Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix


(END) Dow Jones Newswires

July 26, 2021 02:27 ET (06:27 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

1 Year Astrazeneca Chart

1 Year Astrazeneca Chart

1 Month Astrazeneca Chart

1 Month Astrazeneca Chart
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20211209 11:05:50